Galmed Pharmaceuticals Overview

Galmed Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for GLMD.

Quarterly Other Income/Expense

-$1.78M

↓ 8.03% YoY

As of Dec 31, 2025

Annual Other Income/Expense (TTM)

-$1.80M

↑ 45.96% YoY

Trailing 12 months ending Dec 31, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin